Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Currax Pharmaceuticals
Currax Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Onzetra
Sumatriptan
2016-01-27
2024-2036
Cluster headache
,
Migraine disorders
Silenor
Doxepin
2010-03-17
2027-2030
Anxiety disorders
,
Atopic dermatitis
,
Depressive disorder
,
Pain
,
Pruritus
,
Psychotic affective disorders
Treximet
Naproxen
,
Sumatriptan
2008-04-15
2025-2026
Ankylosing spondylitis
,
Back pain
,
Bursitis
,
Common cold
,
Dysmenorrhea
,
Fever
,
Gout
,
Headache
,
Inflammation
,
Juvenile arthritis
,
Osteoarthritis
,
Rheumatoid arthritis
,
Toothache
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Sumatriptan
epilepsy
Doxepin
healthy volunteers/patients
Lorcaserin
obesity
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use